BMRN : BioMarin Pharmaceutical stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
| year | Average | Low | High | Change from close on 2024-09-17 |
|---|---|---|---|---|
| 2024 | $60.54 | $56.35 | $65.54 | -14.19% |
| 2025 | $54.96 | $52.89 | $57.63 | -22.09% |
| 2026 | $50.18 | $44.64 | $56.52 | -28.87% |
| 2027 | $37.35 | $33.33 | $43.53 | -47.05% |
| 2028 | $28.88 | $26.17 | $32.56 | -59.06% |
| 2029 | $24.25 | $23.03 | $25.99 | -65.63% |
| 2030 | $22.19 | $21.55 | $22.89 | -68.54% |
| 2031 | $21.76 | $21.48 | $22.64 | -69.16% |
| 2032 | $39.85 | $23.12 | $58.14 | -43.51% |
| 2033 | $66.4 | $59.35 | $75.74 | -5.88% |
| 2034 | $83.39 | $77.01 | $94.01 | 18.2% |
The 35 Wall Street analysts offering BioMarin Pharmaceutical stock forecast in the last 6 months have average price target of
$102.11 with a high forecast of $122.0 and a low forecast of $72.0.
The average BioMarin Pharmaceutical stock forecast represents a 44.73%
increase from the last price of $70.5500030517578.
For BioMarin Pharmaceutical stock forecast for 2024, 3 predictions are offered for each month of 2024 with average BioMarin Pharmaceutical stock
forecast of $60.54, a high forecast of $65.54, and a low forecast of $56.35.
The average BioMarin Pharmaceutical stock forecast 2024 represents a -14.19%
decrease from the last price of $70.5500030517578.
For BioMarin Pharmaceutical stock forecast for 2025, 12 predictions are offered for each month of 2025 with average BioMarin Pharmaceutical stock
forecast of $54.96, a high forecast of $57.63, and a low forecast of $52.89.
The average BioMarin Pharmaceutical stock forecast 2025 represents a -22.09%
decrease from the last price of $70.5500030517578.
For BioMarin Pharmaceutical stock forecast for 2027, 12 predictions are offered for each month of 2027 with average BioMarin Pharmaceutical stock
forecast of $37.35, a high forecast of $43.53, and a low forecast of $33.33.
The average BioMarin Pharmaceutical stock forecast 2027 represents a -47.05%
decrease from the last price of $70.5500030517578.
For BioMarin Pharmaceutical stock forecast for 2029 (5 year), 12 predictions are offered for each month of 2029 with average BioMarin Pharmaceutical stock
forecast of $24.25, a high forecast of $25.99, and a low forecast of $23.03.
The average BioMarin Pharmaceutical stock forecast 2029 represents a -65.63%
decrease from the last price of $70.5500030517578.
For BioMarin Pharmaceutical stock forecast 2030, 12 predictions are offered for each month of 2030 with average BioMarin Pharmaceutical stock
forecast of $22.19, a high forecast of $22.89, and a low forecast of $21.55.
The average BioMarin Pharmaceutical stock forecast 2030 represents a -68.54%
decrease from the last price of $70.5500030517578.
For BioMarin Pharmaceutical stock forecast for 2034 (10 year), 9 predictions are offered for each month of 2034 with average BioMarin Pharmaceutical stock
forecast of $83.39, a high forecast of $94.01, and a low forecast of $77.01.
The average BioMarin Pharmaceutical stock forecast 2034 represents a 18.2%
increase from the last price of $70.5500030517578.
Please, see more forecasts below.
BMRN : BioMarin Pharmaceutical stock forecast by Wall Street Analysts
The average BioMarin Pharmaceutical stock forecast from last 6 month is $102.11, and this show a -4.17% decrease in average from the prior price target of the each prediction. Also, this average forecast of $102.11 represents a -4.35% decrease from the past average forecast of $106.75, 6 months ago from 16 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-09-17 | Bernstein | $116.0000 | $90.0000 | Outperform |
| 2024-09-17 | Stifel | $115.00 | $87 | Buy |
| 2024-09-17 | B of A Securities | $130 | $115 | Buy |
| 2024-09-17 | RBC Capital | $100.00 | $85 | Sector Perform |
| 2024-09-17 | Wells Fargo | $115.0000 | $90.0000 | Overweight |
| 2024-09-17 | Truist Securities | $118.00 | $90 | Buy |
| 2024-09-17 | Scotiabank | $95.00 | $78.0000 | Sector Perform |
| 2024-09-13 | Canaccord Genuity | $93.0000 | $93 | Hold |
| 2024-09-09 | Cantor Fitzgerald | $110.00 | $110.0000 | Overweight |
| 2024-09-05 | RBC Capital | $100.00 | $100.00 | Sector Perform |
| 2024-09-05 | JP Morgan | $111.0000 | $120.0000 | Overweight |
| 2024-09-05 | Scotiabank | $86.0000 | $95 | Sector Perform |
| 2024-09-05 | Truist Securities | $140.00 | $118 | Buy |
| 2024-09-05 | Piper Sandler | $107.00 | $122 | Overweight |
| 2024-08-27 | Piper Sandler | $107.00 | $107 | Overweight |
| 2024-08-21 | Stifel | $112.00 | $115 | Buy |
| 2024-08-20 | Bernstein | $94.0000 | $110.0000 | Outperform |
| 2024-08-06 | Evercore ISI Group | $113.0000 | $115 | Outperform |
| 2024-08-06 | Barclays | $111.00 | $110.0000 | Overweight |
| 2024-08-06 | RBC Capital | $100.0000 | $100 | Sector Perform |
| 2024-08-06 | Stifel | $108.0000 | $112 | Buy |
| 2024-08-06 | Scotiabank | $85.00 | $86.0000 | Sector Perform |
| 2024-08-06 | TD Cowen | $125.0000 | $120.0000 | Buy |
| 2024-08-05 | Cantor Fitzgerald | $110.00 | $110.00 | Overweight |
| 2024-07-25 | Canaccord Genuity | $89.00 | $89.0000 | Hold |
| 2024-07-22 | Cantor Fitzgerald | $110.00 | $110.0000 | Overweight |
| 2024-06-27 | Wells Fargo | $110.00 | $115.0000 | Overweight |
| 2024-05-17 | Baird | $104.00 | $72 | Neutral |
| 2024-05-14 | Evercore ISI Group | $113 | Outperform | |
| 2024-04-26 | Canaccord Genuity | $91.00 | $89.0000 | Hold |
| 2024-04-26 | Morgan Stanley | $115.0000 | $112 | Overweight |
| 2024-04-25 | Wells Fargo | $100.0000 | $110.0000 | Overweight |
| 2024-04-25 | Cantor Fitzgerald | $110.0000 | Overweight | |
| 2024-04-25 | Scotiabank | $83.0000 | $85.0000 | Sector Perform |
| 2024-04-25 | Citigroup | $94.0000 | $91.0000 | Neutral |
| 2024-02-29 | Canaccord Genuity | $91.0000 | Hold | |
| 2024-02-23 | Piper Sandler | $115.00 | $107 | Overweight |
| 2024-02-23 | Cantor Fitzgerald | $100.0000 | Overweight | |
| 2024-02-23 | RBC Capital | $100.0000 | Sector Perform | |
| 2024-01-30 | Baird | $127.00 | $104.0000 | Outperform |
| 2023-12-21 | Stifel | $101.0000 | Buy | |
| 2023-11-07 | RBC Capital | $100.00 | $100.0000 | Sector Perform |
| 2023-11-03 | BMO Capital | $102.00 | $100.0000 | Outperform |
| 2023-11-02 | Cantor Fitzgerald | $120.00 | $100.0000 | Overweight |
| 2023-11-02 | Barclays | $125.00 | $111.0000 | Overweight |
| 2023-11-02 | Morgan Stanley | $125.0000 | $117 | Overweight |
| 2023-11-02 | Piper Sandler | $125.00 | $115 | Overweight |
| 2023-10-23 | Bernstein | $82.0000 | Market Perform | |
| 2023-10-16 | Cantor Fitzgerald | $120.0000 | Overweight | |
| 2023-09-28 | Raymond James | Market Perform | ||
| 2023-09-25 | Truist Securities | $140.0000 | Buy | |
| 2023-09-18 | UBS | $120.0000 | Buy |
BioMarin Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2024-09-19 | $71.93 | 1.96% |
| 2024-09-20 | $72.06 | 0.18% |
| 2024-09-23 | $73.56 | 2.09% |
| 2024-09-24 | $75.16 | 2.17% |
| 2024-09-25 | $76.58 | 1.89% |
BMRN : Long term BioMarin Pharmaceutical stock forecast for 2024 - 2025 - 2030
Forecast for 2024 Oct. is $65.54 , for 2025 Sep. is $52.89 , for 2028 Sep. is $27.21 , for 2029 Sep. is $23.48 , for 2033 Sep. is $70.34 , and for 2034 Sep. is $94.01.
BMRN : BioMarin Pharmaceutical stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Oct. | $65.54 | -7.10% |
| 2024 Nov. | $59.72 | -8.87% |
| 2024 Dec. | $56.35 | -5.65% |
BMRN : BioMarin Pharmaceutical stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $54.44 | -3.38% |
| 2025 Feb. | $52.98 | -2.69% |
| 2025 Mar. | $53.23 | 0.47% |
| 2025 Apr. | $54.08 | 1.59% |
| 2025 May. | $55.07 | 1.84% |
| 2025 Jun. | $55.99 | 1.66% |
| 2025 Jul. | $57.27 | 2.30% |
| 2025 Aug. | $56.95 | -0.56% |
| 2025 Sep. | $52.89 | -7.14% |
| 2025 Oct. | $53.08 | 0.36% |
| 2025 Nov. | $55.95 | 5.42% |
| 2025 Dec. | $57.63 | 2.99% |
BMRN : BioMarin Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $56.52 | -1.93% |
| 2026 Feb. | $54.01 | -4.44% |
| 2026 Mar. | $51.26 | -5.08% |
| 2026 Apr. | $49.68 | -3.08% |
| 2026 May. | $49.32 | -0.74% |
| 2026 Jun. | $49.80 | 0.98% |
| 2026 Jul. | $50.46 | 1.33% |
| 2026 Aug. | $50.82 | 0.70% |
| 2026 Sep. | $50.36 | -0.90% |
| 2026 Oct. | $48.79 | -3.11% |
| 2026 Nov. | $46.51 | -4.68% |
| 2026 Dec. | $44.64 | -4.02% |
BMRN : BioMarin Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $43.53 | -2.49% |
| 2027 Feb. | $42.56 | -2.22% |
| 2027 Mar. | $41.30 | -2.95% |
| 2027 Apr. | $39.06 | -5.44% |
| 2027 May. | $38.33 | -1.85% |
| 2027 Jun. | $37.05 | -3.36% |
| 2027 Jul. | $35.60 | -3.91% |
| 2027 Aug. | $34.84 | -2.11% |
| 2027 Sep. | $34.52 | -0.93% |
| 2027 Oct. | $34.23 | -0.85% |
| 2027 Nov. | $33.89 | -0.97% |
| 2027 Dec. | $33.33 | -1.66% |
BMRN : BioMarin Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $32.56 | -2.33% |
| 2028 Feb. | $31.72 | -2.57% |
| 2028 Mar. | $30.95 | -2.43% |
| 2028 Apr. | $30.28 | -2.17% |
| 2028 May. | $29.57 | -2.32% |
| 2028 Jun. | $28.93 | -2.18% |
| 2028 Jul. | $28.34 | -2.05% |
| 2028 Aug. | $27.76 | -2.05% |
| 2028 Sep. | $27.21 | -1.97% |
| 2028 Oct. | $26.75 | -1.69% |
| 2028 Nov. | $26.40 | -1.29% |
| 2028 Dec. | $26.17 | -0.91% |
BMRN : BioMarin Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $25.99 | -0.69% |
| 2029 Feb. | $25.79 | -0.73% |
| 2029 Mar. | $25.46 | -1.30% |
| 2029 Apr. | $24.90 | -2.20% |
| 2029 May. | $24.41 | -1.96% |
| 2029 Jun. | $24.02 | -1.58% |
| 2029 Jul. | $23.76 | -1.10% |
| 2029 Aug. | $23.60 | -0.67% |
| 2029 Sep. | $23.48 | -0.53% |
| 2029 Oct. | $23.34 | -0.59% |
| 2029 Nov. | $23.18 | -0.67% |
| 2029 Dec. | $23.03 | -0.67% |
BMRN : BioMarin Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $22.89 | -0.58% |
| 2030 Feb. | $22.79 | -0.43% |
| 2030 Mar. | $22.72 | -0.32% |
| 2030 Apr. | $22.64 | -0.35% |
| 2030 May. | $22.50 | -0.61% |
| 2030 Jun. | $22.31 | -0.87% |
| 2030 Jul. | $22.08 | -1.00% |
| 2030 Aug. | $21.88 | -0.92% |
| 2030 Sep. | $21.73 | -0.70% |
| 2030 Oct. | $21.63 | -0.44% |
| 2030 Nov. | $21.58 | -0.25% |
| 2030 Dec. | $21.55 | -0.15% |
BMRN : BioMarin Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $21.52 | -0.14% |
| 2031 Feb. | $21.49 | -0.11% |
| 2031 Mar. | $21.48 | -0.06% |
| 2031 Apr. | $21.49 | 0.03% |
| 2031 May. | $21.52 | 0.14% |
| 2031 Jun. | $21.56 | 0.21% |
| 2031 Jul. | $21.62 | 0.29% |
| 2031 Aug. | $21.71 | 0.39% |
| 2031 Sep. | $21.83 | 0.57% |
| 2031 Oct. | $22.00 | 0.79% |
| 2031 Nov. | $22.25 | 1.14% |
| 2031 Dec. | $22.64 | 1.74% |
BMRN : BioMarin Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $23.12 | 2.10% |
| 2032 Feb. | $23.66 | 2.36% |
| 2032 Mar. | $24.41 | 3.15% |
| 2032 Apr. | $25.93 | 6.24% |
| 2032 May. | $29.18 | 12.51% |
| 2032 Jun. | $35.34 | 21.12% |
| 2032 Jul. | $43.60 | 23.39% |
| 2032 Aug. | $49.96 | 14.58% |
| 2032 Sep. | $53.17 | 6.42% |
| 2032 Oct. | $55.02 | 3.48% |
| 2032 Nov. | $56.69 | 3.03% |
| 2032 Dec. | $58.14 | 2.56% |
BMRN : BioMarin Pharmaceutical stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $59.35 | 2.08% |
| 2033 Feb. | $60.35 | 1.69% |
| 2033 Mar. | $61.20 | 1.42% |
| 2033 Apr. | $61.99 | 1.29% |
| 2033 May. | $62.92 | 1.50% |
| 2033 Jun. | $64.21 | 2.05% |
| 2033 Jul. | $65.91 | 2.65% |
| 2033 Aug. | $68.03 | 3.21% |
| 2033 Sep. | $70.34 | 3.39% |
| 2033 Oct. | $72.51 | 3.08% |
| 2033 Nov. | $74.28 | 2.45% |
| 2033 Dec. | $75.74 | 1.97% |
BMRN : BioMarin Pharmaceutical stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $77.01 | 1.67% |
| 2034 Feb. | $78.14 | 1.47% |
| 2034 Mar. | $79.20 | 1.35% |
| 2034 Apr. | $80.30 | 1.39% |
| 2034 May. | $81.67 | 1.70% |
| 2034 Jun. | $83.61 | 2.38% |
| 2034 Jul. | $86.43 | 3.37% |
| 2034 Aug. | $90.19 | 4.35% |
| 2034 Sep. | $94.01 | 4.24% |
Frequently Asked Questions about BioMarin Pharmaceutical stock forecast
Is BioMarin Pharmaceutical a good long term stock?
From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2024 Oct. is $65.5380832785988 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2025 Sep. is $52.887040962038 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2028 Sep. is $27.2082436147318 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2029 Sep. is $23.4761641640817 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2033 Sep. is $70.3380180551997 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2034 Sep. is $94.0084292295628
Is BioMarin Pharmaceutical stock overvalued?
BioMarin Pharmaceutical (BMRN) stock is expected to go DOWN . Therefore, AIPickup would say that BioMarin Pharmaceutical (BMRN) stock is overvalued.
Will BioMarin Pharmaceutical stock price go up?
No. The BioMarin Pharmaceutical stock price forecast for 2025 Sep. is $52.887040962038
Is BioMarin Pharmaceutical stock a good buy now?
Since closing price on 2024-09-17 is $70.5500030517578 and forecast for 2025 Sep. is $52.89, BioMarin Pharmaceutical stock is not a good 1 year investment.
14 Days Historical Data for BioMarin Pharmaceutical stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| BMRN stock price for 2024-08-28 | $90.32 | $90.70 | $89.97 | $91.31 |
| BMRN stock price for 2024-08-29 | $91.37 | $90.60 | $90.29 | $93.04 |
| BMRN stock price for 2024-08-30 | $91.21 | $91.46 | $89.95 | $92.35 |
| BMRN stock price for 2024-09-03 | $91.60 | $91.21 | $90.85 | $92.81 |
| BMRN stock price for 2024-09-04 | $89.86 | $91.19 | $87.68 | $92.05 |
| BMRN stock price for 2024-09-05 | $85.12 | $90.01 | $84.89 | $90.01 |
| BMRN stock price for 2024-09-06 | $84.08 | $85.33 | $83.73 | $86.04 |
| BMRN stock price for 2024-09-09 | $84.33 | $84.28 | $83.45 | $84.84 |
| BMRN stock price for 2024-09-10 | $84.85 | $84.48 | $83.69 | $85.64 |
| BMRN stock price for 2024-09-11 | $84.78 | $84.72 | $83.43 | $84.94 |
| BMRN stock price for 2024-09-12 | $84.38 | $84.83 | $83.91 | $85.00 |
| BMRN stock price for 2024-09-13 | $84.90 | $84.43 | $83.95 | $85.00 |
| BMRN stock price for 2024-09-16 | $69.86 | $77.53 | $69.60 | $78.00 |
| BMRN stock price for 2024-09-17 | $70.55 | $70.00 | $68.83 | $71.64 |